Wall Street hopes the worst is behind McDonald's ahead of its Q4 earnings report
McDonald's (MCD) investors were not lovin' 2024 as the fast food chain faced an underperforming stock, lackluster sales, and ...
Amazon reports strong earnings for Q4, but stocks dip due to guidance for the 1st quarter
The Seattle-based e-commerce and technology company said its revenue for the October-December period totaled $187.8 billion, ...
Amazon set to report earnings after the bell
The company is expected to show strong operating income growth, reflecting CEO Andy Jassy’s efforts to rein in expenses.
Ford Motor is set to report earnings after the bell. Here's what Wall Street expects
Wall Street analysts expect Ford to report adjusted earnings per share of 33 cents and revenue of $43.02 billion for the ...
Warner Music Announces New Deal With Spotify as Part of Mixed Earnings Report
Warner Music struck a new deal with Spotify ending the companies’ disputes over a 'bundling' subscription option, as part of ...
MicroStrategy (MSTR) Is About to Report Q4 Earnings Tomorrow: Here’s What to Expect
MicroStrategy (MSTR), the largest corporate holder of Bitcoin (BTC-USD), is scheduled to announce its results for the fourth ...
Peloton (PTON) Is About to Report Q2 Earnings This Week: Here’s What to Expect
Fitness equipment maker Peloton Interactive (PTON) is scheduled to announce its results for the second quarter of Fiscal 2025 ...
Santa Rosa Press Democrat3d
Exchange Bank reports earnings increased in 2024
Exchange Bank (OTC: EXSR) reported Friday a fourth-quarter and annual increases in earnings. Net income for the quarter ended ...
PayPal reports fourth-quarter earnings beat as growth picks up at Venmo
PayPal also announced a new $15 billion share buyback program, and expects to make around $6 billion in repurchases in 2025.
Palantir Earnings Review: Game-Changing Quarter
Palantir is leveraging its Ontology system to scale commercial and government contracts, driving significant AI adoption and ...
Neurocrine Biosciences Reports Mixed Q4
Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.